Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Allergy Therapeutics Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Allergy Therapeutics Plc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Allergy Therapeutics Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Allergy Therapeutics Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Allergy Therapeutics Plc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Allergy Therapeutics Plc, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Ergomed Enters into Co-Development Agreement with Allergy Therapeutics 11
Paladin Labs Enters Into Distribution Agreement With Allergy Therapeutics For Pollinex-R 12
Equity Offering 13
Allergy Therapeutics Raises USD13.9 Million in Public Offering of Shares 13
Allergy Therapeutics Raises Funds in Private Placement of Shares upon Exercise of Warrants and Options 15
Allergy Therapeutics Raises USD17.5 Million in Private Placement of Shares 16
Allergy Therapeutics to Raise USD31 Million in Private Placement of Shares 18
Allergy Therapeutics Raises USD14.5 Million in Private Placement of Shares 19
Allergy Therapeutics Completes Private Placement Of Shares For US$0.3 Million 21
Acquisition 23
Allergy Therapeutics Acquires Alerpharma 23
Allergy Therapeutics Plc – Key Competitors 24
Allergy Therapeutics Plc – Key Employees 25
Allergy Therapeutics Plc – Locations And Subsidiaries 26
Head Office 26
Other Locations & Subsidiaries 26
Recent Developments 28
Financial Announcements 28
Sep 26, 2018: Allergy Therapeutics announces preliminary results for the year ended 30 June 2018 28
Jul 12, 2018: Allergy Therapeutics: Trading Update 33
Mar 07, 2018: Allergy Therapeutics: Interim Results for the six months ended 31 December 2017 34
Sep 28, 2017: Allergy Therapeutics: Preliminary Results 37
Mar 29, 2017: Allergy Therapeutics: Interim Results for the six months ended 31 December 2016 42
Jan 19, 2017: Allergy Therapeutics Provides Trading Update 43
Corporate Communications 44
Nov 08, 2018: Allergy Therapeutics: Director change 44
Jun 06, 2017: Allergy Therapeutics: Directorate changes 45
Feb 08, 2017: Allergy Therapeutics: Directorate Change 46
Product News 47
06/25/2018: Allergy Therapeutics announces publication of data demonstrating long-lasting efficacy of Pollinex Quattro Grass vaccine in Immunotherapy 47
05/29/2018: Allergy Therapeutics – Positive new data with house-dust mite immunotherapy 48
May 14, 2018: Allergy Therapeutics Publishes New Data Validating Mode of Action and Unique Adjuvant Properties of its Patented Adjuvant, Microcrystalline Tyrosine (MCT®), in The Journal of Immunology 49
02/28/2018: Allergy Therapeutics prepares for manufacturing and clinical development of Polyvac Peanut allergy product 50
Clinical Trials 51
May 21, 2018: Allergy Therapeutics announces positive top-line results from its Grass MATA MPL Phase II dose ranging study 51
Feb 12, 2018: Completion of recruitment in PQ Grass Phase II trial 52
Jan 09, 2018: Allergy Therapeutics: PQ Birch Phase III clinical trial completes recruitment 53
Oct 19, 2017: Allergy Therapeutics: Commencement of dosing in PQ Grass Phase II Trial 54
Sep 18, 2017: Allergy Therapeutics: Approval of clinical trial application for PQ Grass Phase II trial 55
Mar 16, 2017: Allergy Therapeutics Announces First Patient Recruited in Pivotal Phase III Birch Immunotherapy B301 Study 56
Feb 14, 2017: Allergy Therapeutics Announces Novel House Dust Mite Allergy Vaccine Gains Clinical Trial Application Approval 57
Feb 01, 2017: Allergy Therapeutics Announces Positive Efficacy and Safety Data Shown in Peanut Allergy Vaccine 58
Other Significant Developments 59
Feb 02, 2018: Allergy Therapeutics Announces Corporate Update 59
Jan 31, 2018: Allergy Therapeutics: Trading Update 61
Appendix 62
Methodology 62
About GlobalData 62
Contact Us 62
Disclaimer 62
Allergy Therapeutics Plc, Pharmaceuticals & Healthcare, Key Facts, 2018 2
Allergy Therapeutics Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Allergy Therapeutics Plc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Allergy Therapeutics Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Allergy Therapeutics Plc, Deals By Therapy Area, 2012 to YTD 2018 9
Allergy Therapeutics Plc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Ergomed Enters into Co-Development Agreement with Allergy Therapeutics 11
Paladin Labs Enters Into Distribution Agreement With Allergy Therapeutics For Pollinex-R 12
Allergy Therapeutics Raises USD13.9 Million in Public Offering of Shares 13
Allergy Therapeutics Raises Funds in Private Placement of Shares upon Exercise of Warrants and Options 15
Allergy Therapeutics Raises USD17.5 Million in Private Placement of Shares 16
Allergy Therapeutics to Raise USD31 Million in Private Placement of Shares 18
Allergy Therapeutics Raises USD14.5 Million in Private Placement of Shares 19
Allergy Therapeutics Completes Private Placement Of Shares For US$0.3 Million 21
Allergy Therapeutics Acquires Alerpharma 23
Allergy Therapeutics Plc, Key Competitors 24
Allergy Therapeutics Plc, Key Employees 25
Allergy Therapeutics Plc, Subsidiaries 26
List of Figures
Allergy Therapeutics Plc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Allergy Therapeutics Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Allergy Therapeutics Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Allergy Therapeutics Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Allergy Therapeutics Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Allergy Therapeutics Plc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Allergy Therapeutics Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Allergy Therapeutics Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9